title: Distinguishing the interactions in the fructose 1,6-bisphosphate binding site of human liver pyruvate kinase that contribute to allostery.
abstract: In the study of allosteric proteins, understanding which effector-protein interactions contribute to allosteric activation is important both for designing allosteric drugs and for understanding allosteric mechanisms. The antihyperglycemic target, human liver pyruvate kinase (hL-PYK), binds its allosteric activator, fructose 1,6-bisphosphate (Fru-1,6-BP), such that the 1'-phosphate interacts with side chains of Arg501 and Trp494 and the 6'-phosphate interacts with Thr444, Thr446, Ser449 (i.e., the 444-449 loop), and Ser531. Additionally, backbone atoms from the 527-533 loop interact with a sugar ring hydroxyl and the two effector phosphate moieties. An effector analogue series indicates that only one phosphate on the sugar is required for activation. However, singly phosphorylated sugars, including Fru-1-P and Fru-6-P, bind with a Kix in the range of 0.07-1 mM. The second phosphate of Fru-1,6-BP causes tight effector binding, because this native effector has a Kix of 0.061 μM. Glucose 1,6-bisphosphate and ribulose 1,5-bisphosphate bind in the 0.07-1 mM range. The contrast with a higher Fru-1,6-BP binding indicates specificity for the fructose sugar conformation. Site-directed random mutagenesis at each residue that contacts bound Fru-1,6-BP showed that a negative charge introduced at position 531 mimics allosteric activation, even in the absence of Fru-1,6-BP. Collectively, analogue and mutagenesis studies are consistent with the 527-533 loop playing a key role in allosteric function. Deletion mutations that shortened the 527-533 loop were expected to prevent formation of hydrogen bonds between backbone atoms on the loop and Fru-1,6-BP. Indeed, Fru-1,6-BP did not activate these loop-shortened mutant proteins. Previous structural comparisons of M1-PYK and M2-PYK indicate that the 527-533 loop makes interactions across a subunit interface when an activator is not present. Mutating the hL-PYK subunit interface interactions among Trp527, Arg528, and Asp499 mimics allosteric activation. Considered with published structures, these results are consistent with (1) the two phosphates of Fru-1,6-BP docking to Arg501/Trp494 and the 444-449 loop, respectively, and (2) the formation of hydrogen bonds among Fru-1,6-BP and backbone atoms of the 527-533 loop pulling this loop away from the subunit interface, which results in breaking of the Trp527-Arg528-Asp499 interactions to elicit an allosteric response.
authors: Department of Biochemistry and Molecular Biology, The University of Kansas Medical Center , Kansas City, Kansas 66160, United States.
authors: Arjun
authors: A
authors: Ishwar
authors: Qingling
authors: Q
authors: Tang
authors: Aron W
authors: AW
authors: Fenton
mesh_terms: D000494:Allosteric Regulation; D001665:Binding Sites; D005635:Fructosediphosphates / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D008099:Liver / Q000201:enzymology*; D008958:Models, Molecular; D016296:Mutagenesis; D009154:Mutation; D011770:Pyruvate Kinase / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*
chemical_list: D005635:Fructosediphosphates; D011770:Pyruvate Kinase; C029063:fructose-1,6-diphosphate
references: Biochemistry. 2011 Mar 22;50(11):1934-9
references: 21261284
references: Curr Med Chem. 2010;17(25):2804-21
references: 20586715
references: FEBS Lett. 1976 Mar 15;63(1):17-21
references: 770188
references: Biochemistry. 2005 Jul 12;44(27):9417-29
references: 15996096
references: Biochemistry. 2005 Mar 1;44(8):3112-21
references: 15723556
references: J Mol Biol. 1995 May 12;248(4):845-55
references: 7752245
references: Trends Biochem Sci. 2008 Sep;33(9):420-5
references: 18706817
references: Methods Enzymol. 2004;380:187-203
references: 15051338
references: Arch Biochem Biophys. 1970 Nov;141(1):98-101
references: 5480130
references: Biochemistry. 2013 Jan 22;52(3):466-76
references: 23270483
references: Biochim Biophys Acta. 1972 Mar 8;258(3):763-8
references: 5017700
references: J Biol Chem. 1959 Apr;234(4):815-20
references: 13654269
references: Biochemistry. 1995 Nov 21;34(46):15006-20
references: 7578114
references: Methods Enzymol. 2009;466:83-107
references: 21609859
references: Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5881-6
references: 23530218
references: Arch Biochem Biophys. 2009 Apr 1;484(1):16-23
references: 19467627
references: Bioorg Med Chem. 2009 Aug 1;17(15):5414-9
references: 19595601
references: J Biol Chem. 1988 Apr 25;263(12):5534-42
references: 3356696
references: FEBS Lett. 1970 Jan 15;6(1):43-45
references: 11947332
references: J Biol Chem. 2006 Sep 15;281(37):26951-65
references: 16837469
references: J Biol Chem. 2002 Jun 28;277(26):23807-14
references: 11960989
references: Biochemistry. 2006 May 2;45(17):5421-9
references: 16634623
references: Structure. 1998 Feb 15;6(2):195-210
references: 9519410
references: Biochemistry. 1973 Feb 27;12(5):863-70
references: 4346925
references: Biochemistry. 2009 May 12;48(18):3816-8
references: 19320443